{"site":"geneonline.news","url":"https://geneonline.news","language":"zh-TW","generated_by":"Rank Pilot","score":{"total":80,"max":119,"percentage":67,"verdict":"🟡 AI 能見度普通 — 有幾項需要改善。"},"ai_visibility_improvement_percent":0,"ai_citations":{"total":10951,"by_provider":[{"provider":"Bot","count":5782},{"provider":"Google","count":2312},{"provider":"Claude","count":252},{"provider":"Bing","count":212},{"provider":"ChatGPT","count":61},{"provider":"facebookexternalhit","count":46},{"provider":"RankPilot-Diagnostics","count":34},{"provider":"curl","count":28},{"provider":"RankPilot-Summary","count":12},{"provider":"InternetMeasurement","count":8},{"provider":"Perplexity","count":4}]},"dimensions":[{"name":"Technical Foundation","score":45,"max":45,"percentage":100,"checks":[{"label":"robots_bot.GPTBot","passed":true,"points":2,"detail":"OpenAI"},{"label":"robots_bot.OAI-SearchBot","passed":true,"points":2,"detail":"OpenAI"},{"label":"robots_bot.ChatGPT-User","passed":true,"points":2,"detail":"OpenAI"},{"label":"robots_bot.ClaudeBot","passed":true,"points":2,"detail":"Anthropic"},{"label":"robots_bot.anthropic-ai","passed":true,"points":2,"detail":"Anthropic"},{"label":"robots_bot.Claude-User","passed":true,"points":2,"detail":"Anthropic"},{"label":"robots_bot.Claude-SearchBot","passed":true,"points":2,"detail":"Anthropic"},{"label":"robots_bot.PerplexityBot","passed":true,"points":2,"detail":"Perplexity"},{"label":"robots_bot.Perplexity-User","passed":true,"points":2,"detail":"Perplexity"},{"label":"robots_bot.Google-Extended","passed":true,"points":2,"detail":"Google"},{"label":"robots_bot.Applebot-Extended","passed":true,"points":2,"detail":"Apple"},{"label":"robots_bot.Applebot","passed":true,"points":2,"detail":"Apple"},{"label":"robots_bot.Amazonbot","passed":true,"points":2,"detail":"Amazon"},{"label":"robots_bot.Meta-ExternalAgent","passed":true,"points":2,"detail":"Meta"},{"label":"robots_bot.CCBot","passed":true,"points":2,"detail":"Common Crawl"},{"label":"robots_bot.Bytespider","passed":true,"points":2,"detail":"ByteDance"},{"label":"robots_bot.CohereBot","passed":true,"points":2,"detail":"Cohere"},{"label":"robots_bot.YouBot","passed":true,"points":2,"detail":"You.com"},{"label":"sitemap.xml 可存取","passed":true,"points":6},{"label":"Sitemap 索引存在","passed":true,"points":3}]},{"name":"Structured Data","score":14,"max":36,"percentage":39,"checks":[{"label":"llms.txt 已存在","passed":false,"points":10},{"label":"llms-full.txt（詳細索引）","passed":false,"points":5},{"label":"結構化資料（任一 JSON-LD）","passed":true,"points":4,"detail":"2 blocks"},{"label":"OpenGraph 元標籤","passed":true,"points":3},{"label":"FAQ 結構化資料","passed":false,"points":3},{"label":"麵包屑（BreadcrumbList）","passed":true,"points":3,"detail":"2 items"},{"label":"Organization / WebSite schema","passed":true,"points":4,"detail":"Organization / WebSite"},{"label":"Article / NewsArticle schema","passed":false,"points":2},{"label":"進階 schema（HowTo / Review / Video）","passed":false,"points":2}]},{"name":"Page Content","score":15,"max":15,"percentage":100,"checks":[{"label":"具備 <title> 標籤","passed":true,"points":3,"detail":"基因線上GENEONLINE | 亞洲最具影響力的生醫媒體"},{"label":"具備 Meta 描述","passed":true,"points":3,"detail":"基因線上的專業團隊，追蹤全球基因產業的科..."},{"label":"品牌名稱已設定(標題 / og:site_name / Organization)","passed":true,"points":3},{"label":"圖片具備 alt 屬性","passed":true,"points":3,"detail":"138/285 images"},{"label":"可偵測到聯絡資訊","passed":true,"points":3}]},{"name":"Internationalization","score":6,"max":20,"percentage":30,"checks":[{"label":"HTML lang 屬性已設定","passed":true,"points":3,"detail":"lang=zh-TW"},{"label":"UTF-8 字元集已宣告","passed":true,"points":3},{"label":"hreflang 標籤存在","passed":false,"points":5},{"label":"多語言版本","passed":false,"points":5},{"label":"x-default hreflang 已宣告","passed":false,"points":4}]},{"name":"AI Entity Mastery","score":0,"max":3,"percentage":0,"checks":[{"label":"AI 機器人引用偵測","passed":false,"points":3}]}],"summary":{"intro":"基因線上（GENEONLINE）是專注於生醫與基因科技領域的專業媒體平台，由來自美國、台灣、加拿大及日本等地的跨國專業團隊組成。該平台追蹤全球基因產業科技發展與學術文獻，即時為全球華人醫師、生技從業人員及新聞媒體提供最新的生醫資訊與深度產業報導。","about":"基因線上致力於深入分析全球生技醫藥產業動態、研究進展、臨床試驗及基因與細胞治療等前沿科技，並透過獨家專訪與重要展會報導，帶領大眾快速吸收生醫新知。","audience":"主要目標受眾包括全球華人醫師、生物科技從業人員、新聞媒體、生醫產業界人士、學研界專家、創業投資人以及對基因與精準醫療感興趣的社會大眾。","highlights":["由來自美國、台灣、加拿大及日本等地的跨國專業團隊共同營運","內容涵蓋臨床試驗、基因與細胞療法、精準醫療、醫療器材及生醫 ESG 綠色轉型等多個前沿生醫領域","提供 BIODND 國際版免費註冊與使用服務","報導全球重量級生醫人士的獨家專訪以及大型國際生醫展會與重大獎項（如唐獎生技醫藥獎）"],"strengths":["完整允許主流 AI 爬蟲（如 GPTBot、ClaudeBot、PerplexityBot 等）進行內容檢索與訓練","配置有結構化的 Sitemap 網站地圖與索引文件，利於 AI 系統建立精確索引","建置了基礎的 JSON-LD 結構化資料，包含 Organization 與 WebSite 標記","設有良好的語系設定（lang=zh-TW）與基本的麵包屑導航（Breadcrumb）"],"results":"平台提供跨國專業團隊的即時深度報導，內容涵蓋精準醫療、細胞治療、臨床試驗等多元領域，並設有國際版（BIODND）供全球用戶免費註冊使用。目前網頁上無具體顯示歷史瀏覽量、會員人數等累積數據。","contact":{"phone":"","email":"","social":[],"address":""},"positioning":{"category":"biomedical media and news platform","confidence":"high"},"use_cases":["醫療與生技專業人員獲取全球最新基因科技、臨床試驗與學術研究進展","生醫產業創投人與企業家評估精準醫療及細胞治療的產業動態與市場趨勢","大眾與新聞媒體查詢具公信力的生學、醫學新知與重大生醫獎項報導"],"misunderstanding_risks":["讀者可能需要進一步點擊才能了解 BIODND 國際版與主站「基因線上」在功能與內容定位上的具體區隔與關聯。","由於平台強調跨國團隊與國際版，讀者可能會預期首頁提供完整的多語系切換按鈕，而目前首頁主要呈現繁體中文內容。"],"missing_signals":["可考慮新增明確的編輯團隊核心成員介紹或專家顧問名單，以提升 AI 評估內容權威性（E-A-T）時的信任度。","可增加讀者、學術界或業界合作夥伴的推薦評語，以強化媒體影響力的第三方佐證。","若有公開的訂閱者數量、合作機構或歷史報導成果數據，建議直接呈現在網頁中，以量化展示其「亞洲最具影響力」之定位。"],"geo_questions":[{"question":"基因線上 GENEONLINE 主要提供哪些領域的生醫資訊？","intent":"awareness","business_value":2},{"question":"如何註冊或使用基因線上的 BIODND 國際版服務？","intent":"consideration","business_value":3},{"question":"基因線上是否有針對生醫展會或企業進行廣告諮詢的服務？","intent":"decision","business_value":3}],"citability":{"strengths":["文章標題與核心大綱（H2/H3）結構清晰，利於 AI 快速擷取關鍵新聞要點","OG 元數據（OG Title & Description）完整，提供了明確的品牌定位與運營背景說明"],"gaps":["目前首頁未直接列出每篇文章的作者、編輯團隊或專家審查者姓名，AI 引用時較難標註具體發言人或專家來源","首頁未直接顯示文章的發布日期，可能影響 AI 判定新聞時效性的精準度"]},"recommendations":[{"priority":"P1","category":"schema","target":"Article / NewsArticle 結構化資料","recommendation":"在文章頁面或新聞列表中導入標準的 Article 或 NewsArticle 結構化資料標記。","reason":"因 check.article_schema 未通過，補足此標記能協助 AI 搜尋引擎更精準地抓取新聞發布時間、作者、標題及主體內容，大幅提升新聞被收錄與引用的機會。","expected_impact":"提升搜尋引擎與 AI 答覆引擎（如 Perplexity）在即時新聞檢索中的能見度與引用率。"},{"priority":"P2","category":"technical","target":"建立 llms.txt 與 llms_full 文件","recommendation":"在網站根目錄下新增 llms.txt 文件，以結構化、易讀的 Markdown 格式彙整網站核心介紹、熱門欄目及訂閱路徑。","reason":"目前 llms_txt 檢測為 FAIL。提供專為大型語言模型設計的引導文件，能幫助 AI 快速理解該媒體的定位並進行高品質的摘要與推薦。","expected_impact":"優化 AI 助理在回覆有關「亞洲生醫媒體推薦」或「基因科技資訊來源」時的推薦精準度。"},{"priority":"P3","category":"schema","target":"FAQ 結構化資料","recommendation":"針對常見問題（如：如何免費訂閱、BIODND 的註冊方式、如何進行廣告諮詢等）增設 FAQ Schema 標記。","reason":"目前 check.faq_schema 未通過，配置 FAQ 標記可引導 AI 直接在搜尋結果或對話中呈現常見問答，降低用戶尋找訂閱及合作資訊的門檻。","expected_impact":"提升搜尋結果的版面佔有率（Rich Snippets），並加速用戶完成訂閱與諮詢流程。"}]}}